IMIDAZOLE COMPOUNDS AND THEIR USE AS ADENOSINE DEAMINASE INHIBITORS
申请人:FUJISAWA PHARMACEUTICAL CO., LTD.
公开号:EP1261589A1
公开(公告)日:2002-12-04
US6908940B2
申请人:——
公开号:US6908940B2
公开(公告)日:2005-06-21
[EN] IMIDAZOLE COMPOUNDS AND THEIR USE AS ADENOSINE DEAMINASE INHIBITORS<br/>[FR] COMPOSES D'IMIDAZOLE ET LEUR UTILISATION EN TANT QU'INHIBITEURS D'ADENOSINE DESAMINASE
申请人:FUJISAWA PHARMACEUTICAL CO
公开号:WO2001053271A1
公开(公告)日:2001-07-26
Imidazole compounds having adenosine deaminase inhibitory activity represented by the formula (I) wherein R1 is aryloxy, or aryl which is optionally substituted with suitable substituent(s); R2 is lower alkyl; R3 is hydroxy or protected hydroxy; and - A - is lower alkylene, its prodrug, or their salt. The compounds are useful for treating and/or preventing diseases for which adenosine is effective.
Imidazole compounds and their use as adenosine deaminase inhibitors
申请人:——
公开号:US20040097571A1
公开(公告)日:2004-05-20
Imidazole compounds having adenosine deaminase inhibitory activity represented by the formula (I) wherein R
1
is aryloxy, or aryl which is optionally substituted with suitable substituent(s); R
2
is lower alkyl; R
3
is hydroxy or protected hydroxy; and -A- is lower alkylene, its prodrug, or their salt. The compounds are useful for treating and/or preventing diseases for which adenosine is effective.
1